Completed PHASE4 INTERVENTIONAL NCT00940927

Dose-response of Albuterol in Asthmatics

Exclusion of Asthmatics From Clinical Trials Due to the 15 Percent Rule

Sponsor: Nemours Children's Clinic

Conditions Asthma

Interventions albuterol

Updated 8 times since 2017 Last updated: Apr 14, 2015 Started: Jul 31, 1993 Primary completion: Oct 31, 1994 Completion: Oct 31, 1994

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Asthma, this trial is completed. The trial is conducted by Nemours Children's Clinic and has accumulated 8 data snapshots since 1993. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nemours Children's Clinic

Data source: Nemours Children's Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jacksonville, United States